Introduction
One of the characteristic features of ulcerative colitis is epithelial destruction 111 with an accompanying reduction in the amount of mucus, which may be proportional to the activity of the Correspondence: Professor J. R. Clamp, Department of Medicine, University of Bristol, Bristol Royal Infirmary, Bristol BS2 SHW, U.K. disease [21. The mucus depletion found in ulcerative colitis is in contrast with the changes found in Crohn's disease of the colon and this may be useful in differentiating the two diseases. Apart from changes in the amount of mucus, there is some evidence that there may be changes in the nature of mucus itself. Thus differences have been found 131 in the carbohydrate content of mucus in ulcerative colitis and between ulcerative colitis and Crohn's disease of the colon (J. R. Clamp & R. Teague, unpublished work) . To assess these changes it is necessary to isolate the glycoproteins from colonic mucosa and investigate the nature and distribution of the constituent oligosaccharide units.
The principal component of mucus and the component that confers on the secretion its characteristic physicochemical properties is a high-molecular-weight glycoprotein. This glycoprotein consists of a long polypeptide chain, which is rich in proline, serine and threonine. To every hydroxyamino acid (serine and threonine) is attached an oligosaccharide unit, and a typical polypeptide chain will possess many hundreds of such units surrounding and shielding the chain from proteolytic enzymes. The polypeptides have stretches that are devoid of carbohydrate ('naked' peptide regions) where the chains can come together and be linked through the disulphide bonds of cystine.
The oligosaccharide units are attached through N-acetylgalactosamine to serine or threonine and, in addition to the linkage monosaccharide, may contain residues of fucose, galactose, N-acetylglucosamine and sialic acid [41. The presence of certain non-reducing terminal residues determines the blood-group activity of mucus glycoproteins, for example N-acetylgalactosamine in blood group A and galactose in blood group B. The number, size and carbohydrate content of the oligosaccharide units are of interest in determining the properties of the glycoprotein and therefore the role that mucus plays in protecting the gastrointestinal mucosa.
Methods
Normal colons were obtained post mortem within 24 h of death from 10 patients without evidence of gastrointestinal disease.
Ten diseased colons were obtained at operations for colectomy from patients with total ulcerative colitis. Eight were resected from cases of severe acute disease not responding to medical treatment and two were from quiescent cases, with a history of active disease in the past.
Four colons were obtained from patients with severe Crohn's disease of the colon. Each specimen had large areas involved in the disease process.
Colons were divided longitudinally to expose the luminal surface, which was washed with distilled water to remove any faecal or loosely adherent material. The mucosa was then gently scraped with a glass slide and the scrapings were suspended in sodium chloride solution (150 mmol/l) (100 ml) with sodium azide (0.02%). The suspension was homogenized and centrifuged at 38000 g for 45 min. The supernatant was collected and the sediment suspended in fresh solution (100 ml) and shaken at 4°C for 18 h. The suspension was centrifuged as before and the sediment subjected to a further extraction step.
The combined supernatant solutions and the final sediment were dialysed against distilled water and freeze-dried. From this stage all the preparative steps were carried out as separate work-ups (at least six of each specimen.
Samples (100 mg) of the supernatant fractions were subjected to gel-permeation chromatography on a column (65 cm x 2.4 cm internal diameter) of Sepharose 2B (Pharmacia Ltd) in sodium chloride (150 mmol/l)/sodium phosphate (20 mmol/l) buffer (pH 7.0). The effluent was monitored for hexose by the phenol/sulphuric acid method [51 and the fractions were pooled according to the profile, to give excluded (Sl) and included (S2) fractions.
The mucus glycoprotein-containing fraction S 1 (10 mg) was dissolved in guanidinium chloride (6 mol/l)/Tris buffer (0.5 mol/l) at pH 8.5 (0.5 ml), containing 0.1 mmol of dithiothreitol. The mixture was allowed to stand at 37OC for 90 min. At the end of this time, iodoacetamide (0.24 mol/l in the same buffer) (0.5 ml) was added and the mixture left for a further 60 min. The final solution was dialysed, freeze-dried and subjected to gel-permeation chromatography as described above.
The mucus glycoprotein-containing fraction (25 mg/ml) was incubated at 37°C with Pronase (2.5%, w/w) in calcium chloride solution (10 mmol/l) adjusted to, and maintained at, pH 8.0 with sodium hydroxide solution (20 mmol/l). After 24 h a further addition of Pronase was made (2.5%, w/w) and the digestion continued for a further 24 h. At the end of this time the incubation mixture was dialysed and freeze-dried. The dried material was subjected to gel-permeation chromatography as described above to give a glycopolypeptide fraction.
Analytical density gradient ultracentrifugation was carried out in caesium bromide solution (1 -4 g/l) with a Beckman Spinco model E analytical centrifuge [61.
Mucus glycoprotein (50 mg) was incubated at 45°C for 215 h in a solution (20 ml) of potassium hydroxide (0.25 mol/l) containing sodium borohydride (1 mol/l) [71. At the end of this period the pH was adjusted to 5.0 with acetic acid and the solution freeze-dried. The dried material was extracted with water (8 ml), centrifuged (30 000 g for 30 min) and the supernatant solution freezedried. This dried material was further extracted with water (2 ml) and centrifuged as before. The final supernatant was applied to a column (150 cm x 1.2 cm i.d.) of Sephadex G-10 and eluted with water. The carbohydrate-containing peak was freeze-concentrated and applied to a column (150 cm x 1.4 cm i.d.) of Sephadex G-50 and eluted with water. Fractions were pooled according to the hexose profile. The totally included fraction was fractionated on a column (150 cm x 1.2 cm i.d.) of Sephadex G-25 and the effluent pooled according to the hexose profile.
The carbohydrate content of glycoproteins, glycopolypeptides and oligosaccharides was determined by gas chromatography by the method of Clamp [Sl where all material was subjected to at least three separate analyses.
Results
Results were assessed by Student's t-test in which P < 0.01 was regarded as significant.
As might be expected, a greater amount of material was obtained from the mucosal scrapings of colons with active disease than from normal colons, although this difference did not approach significance. Just over half the scrapings could be rendered soluble and this soluble fraction contained about 70% of the carbo- hydrate of the original material. The soluble material contained the monosaccharides characteristic of mucus glycoproteins but the total carbohydrate content was low, indicating that a considerable amount of other material was present. The soluble material was therefore fractioned on columns of Sepharose 2B. Two carbohydrate-containing fractions (S 1 and S2) were obtained. The first peak (Sl) was eluted at the void volume, indicating a molecular weight of several millions. Fraction S1 contained the mucus glycoproteins, and this was confirmed by analytical density gradient ultracentrifugation, which showed an almost symmetrical twin-lobed pattern with a buoyant density of 1.482 g/ml characteristic of such glycoproteins. There were significant differences in the carbohydrate analyses of the normal and diseased colons ( Table 1) . The carbohydrate content of S1 was significantly reduced in the active ulcerative colitis group, although not to the same extent in the inactive group or in those with Crohn's colitis. In addition, S1 from the active diseases accounted for a lower proportion of material eluted from the column both in terms of weight and amount of carbohydrate. Again the-results from inactive colitis showed some changes, but these were not significant. However, the total carbohydrate content even of the normal material was only 36%, suggesting the presence of other protein material. Density gradient ultracentrifugation showed, in addition to the mucus glycoprotein, material concentrated at the meniscus which would be compatible with protein contamination. Possibly the cross-linked structure of the mucus gel interfered with efficient gel-permeation chromatographic separation of the protein. The high-mdecular-weight fraction was accordingly reduced and alkylated and then subjected to gel-permeation chromatography. After this treatment, the carbohydrate content of the normal material increased to 52% ( Table 2 ). The carbohydrate content of the disease material also increased, but was still significantly lower than that of normal material. To be sure that the lower values of carbohydrate in the disease material was not the result of remaining protein contamination, the material was exhaustively digested with Pronase. After this treatment, the carbohydrate content of normal and disease material did not increase significantly over the reduced and alkylated material (Table 2) .
Oligosaccharides were prepared by alkaline /I-elimination in the presence of sodium borohydride, This technique cleaves the bond between the oligosaccharide units and the polypeptide chain and reduces the. linkage N-acetylgalactosamine to the corresponding glycitol (N-acetylgalactosaminitol). After this procedure, more than 70% of the carbohydrate was recovered in Table 3 . Every unit must possess a single residue of N-acetylgalactosaminitol and this glycitol therefore provides an equivalent weight for the unit. In addition, the proportions of the other monosaccharides to one residue of N-acetylgalactosaminitol establishes the composition of the fraction. In the normal group more than 50% of the oligosaccharide units contained eight or more monosaccharide residues. In the ulcerative colitis group only 22% of the units and in Crohn's disease only 26% possessed this number of residues.
Discussion
Colonic however, excluded from Sephadex G-100, indicating the molecular weight was about 1.5 x lo5. Fraction S1 is mainly composed of mucus glycoprotein with the characteristic ultracentrifugation behaviour and carbohydrate content ( Table 1 ) of such material. The amount of mucus glycoprotein material obtained from patients with active ulcerative colitis was much reduced compared with normal, in agreement with the histochemical findings 111. In addition to the reduced amount of mucus glycoprotein present in the mucosa in active disease, there is a lower content of carbohydrate in the mucus glycoprotein itself. This is shown in the high-molecular-weight material S 1 ( Table 1) .
Some of the changes observed in active disease are due to the presence of additional protein material, presumably from the inflammatory exudate. Fraction S2 is different from S1 in both molecular weight and carbohydrate composition. It is of interest therefore that the proportion of this lower-molecular-weight material is increased in both active diseases, but not in inactive disease (Table 1) Although, as mentioned above, the carbohydrate content of S 1 was lower in active disease than in normal material, the ultracentrifugation results showed that there was some protein contamination at this stage. Attempts were therefore made to purify the mucus glycoprotein by gel-permeation chromatography after reduction and alkylation of the disulphate linkages. These linkages play an important part in the three-dimensional structure of mucus [ 171 and by breaking these bonds any protein trapped in the gel or disulphide-linked will be released. The carbohydrate content increased markedly after this procedure (Table 2) . However, the disease material still had a carbohydrate content of only about 30% and it was decided therefore to incubate the material with Pronase. This proteolytic enzyme has a wide specificity and converts mucus glycoprotein into glycopolypeptide, which is still of high molecular weight [18, 191. Any protein remaining in the material would be digested and the resulting low-molecular-weight peptides would be removed on dialysis or gel-permeation chromatography. However, after this treatment the carbohydrate did not change significantly from that obtained after reduction and alkylation. In both active diseases therefore the carbohydrate content of the mucus glycopolypeptides was only about 30%. This could be the result of fewer oligosaccharide units in the glycoprotein or smaller oligosaccharide units, or a combination of the two. In an attempt to partially resolve this problem the oligosaccharide units were cleaved from the glycoprotein and fractionated as shown in Table 3 .
The monosaccharide contents of the oligosaccharides from normal and disease material were similar in containing galactose and Nacetylglucosamine in approximately equimolar amounts with lower proportions of fucose and N-acetylneuraminic acid. All the normal oligosaccharides contained N-acetylgalactosamine, whereas those from diseased colons contained little or none of this monosaccharide. N-Acetylgalactosamine may be present in one of two positions in the oligosaccharide unit, namely as the linkage sugar or as a non-reducing terminal residue. As the linkage sugar has been converted into the glycitol, the surviving N-acetylgalactosamine must be a terminal residue. The differences between normal and disease material would indicate therefore that the latter has incomplete oligosaccharide units. Both materials yielded the same size spectrum of oligosaccharides, ranging from about three monosaccharide residues up to 12 or more residues. However, the materials differed markedly in the molar percentage distribution of oligosaccharide units. Almost two-thirds of the oligosaccharide units from normal material contained eight or more monosaccharide residues, whereas more than three-quarters of those from disease material contained fewer than eight residues. These results indicate that the lower carbohydrate content of disease material is at least partly the result of smaller oligosaccharide units. There are at least four possible explanations for this finding.
Active colonic disease is associated with some degree of cell breakdown and possibly with the release of lysosomal hydrolases. There may therefore be sufficient glycosidase activity in the colon to reduce the size of the oligosaccharide units in disease material.
In the inflammatory process there may be stimulation of mucus production as part of the healing process. This is supported by the increased rate of glycoprotein synthesis that has been observed 1201 in ulcerative colitis. This is evidence that mucus glycoprotein preparations vary in both degree of glycosylation and size of oligosaccharide unit 12 11 and that prolonged stimulation of mucus secretion is accompanied by a reduction in the numbers of peripheral monosaccharide residues (J. R. Clamp & C. F. Phelps, unpublished work). Thus the increased rate of mucus glycoprotein production may result in incomplete biosynthesis of the oligosaccharide units.
Another possibility is that the mucusproducing cell itself is lost more rapidly. There is evidence that the epithelial cell turnover rate is markedly increased in ulcerative colitis [22, 231 . The short cell life would result in the release of incomplete glycoprotein molecules, mainly affecting the carbohydrate portion since this represents the last stage in the biosynthetic process.
The final possibility is that the disease has a direct toxic effect on the biosynthetic mechanism. This could follow from a general effect on cellular metabolism or be the result of a more specific effect on the many factors involved in glycoprotein biosynthesis. In the case of the oligosaccharide units this could be the synthesis of the constituent monosaccharides, their activation to the nucleotide derivative or their transfer to the carbohydrate moiety.
Whichever of these or other explanations is operative, the fact remains that these colonic diseases are accompanied by a reduction in the amount of mucus glycoprotein and in the ratio of glycoprotein to protein, and by changes in the oligosaccharide units.
